 Biomerica NASDAQ: BMRA is one of 27 publicly-traded companies in the Diagnostic substances industry, but how does it weigh in compared to its competitors? We will compare Biomerica to similar businesses based on the strength of its profitability, analyst recommendations, valuation, risk, institutional ownership, dividends and earnings. Risk and Volatility Biomerica has a beta of ... 